Pricing Log in Create free account

Kymera Therapeutics, Inc. (KYMR) vs Bio-Techne Corp (TECH)

Kymera Therapeutics, Inc. and Bio-Techne Corp are both Biotechnology companies. Kymera Therapeutics, Inc. and Bio-Techne Corp are of similar size ($11.4B and $10.8B). Kymera Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Bio-Techne Corp trades at 62.1×. Kymera Therapeutics, Inc. grew revenue faster over the last twelve months: 134.8% against −0.38%. Bio-Techne Corp has the higher net margin (15.0% vs 0.00%) and the higher return on invested capital (7.70% vs −39.3%). Across the 19 metrics below, Bio-Techne Corp leads on 15 and Kymera Therapeutics, Inc. on 4.

Valuation

Metric KYMR TECH Biotechnology median
P/E n/m 62.11 10.71
P/S 122.15 9.33 9.84
P/B 7.94 5.38 2.15
Price to free cash flow n/m 43.06 25.78
EV/EBITDA n/m 32.30 0.65
EV/Sales 112.90 9.29 9.47
Earnings yield (2.82%) 1.61% (34.53%)
Free cash flow yield (2.25%) 2.32% (24.00%)

Profitability

Metric KYMR TECH Biotechnology median
Gross margin 100.00% 65.77% 69.20%
Operating margin 0.00% 20.73% 0.00%
Net margin 0.00% 14.97% 0.00%
Free cash flow margin 0.00% 21.66% 0.00%
Return on equity (27.29%) 9.03% (53.10%)
Return on assets (24.36%) 7.07% (46.06%)
Return on invested capital (39.30%) 7.70% 0.00%

Growth

Metric KYMR TECH Biotechnology median
Revenue growth (TTM) 134.84% (0.38%) 5.26%
EPS growth (last fiscal year) (23.83%) 152.17% 29.88%
Revenue growth, 5-year CAGR 2.87% 5.47% 9.75%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric KYMR TECH Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 11.13 4.55 4.98
Net debt to EBITDA 2.42 (0.19) 1.01

Dividend

Metric KYMR TECH Biotechnology median
Dividend yield — 0.44% 0.39%
Payout ratio — 0.28 —

Size

Metric KYMR TECH Biotechnology median
Market cap 10.81b 11.41b 171.46m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack